Leukemia/Lymphoma Immunophenotyping by Flow Cytometry, Tissue
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Evaluation of tissues for potential involvement by a lymphoproliferative disorder or acute leukemia
Reflex Tests Lists test(s) that may or may not be performed, at an additional charge, depending on the result and interpretation of the initial test(s)
|Test ID||Reporting Name||Available Separately||Always Performed|
|88465||Flow Cytometry Interp, 2-8 Markers||No, (Bill Only)||No|
|88466||Flow Cytometry Interp, 9-15 Markers||No, (Bill Only)||No|
|88467||Flow Cytometry Interp,16 or greater||No, (Bill Only)||No|
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
When this test is ordered, a screening panel and a professional interpretation will always be charged. The screening panel will be charged based on number of makers tested (80997 for first marker, 81047 for each additional marker). The interpretation will be set based on markers tested in increments of 9 to 15, or 16 and greater. In addition, reflex testing may occur to fully characterize a disease state or clarify any abnormalities from the screening test. Reflex tests will be performed at an additional charge for each marker tested (80997 if applicable, 81047 if applicable).
Note: FISH testing may be recommended by the Mayo pathologist in some cases. They will contact the referring physician or pathologist to confirm the addition of these tests.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Includes flow cytometric analysis with an assortment of lymphocyte- and/or myeloid-lineage associated antigens. The appropriate selection of these is chosen by a Mayo Hematopathologist based on clinical information, specimen type, specimen volume, cellular characteristics, and/or morphologic review, keeping in mind the clinical impression of the referring physician. This test also includes review of morphology for quality correlation with immunophenotypic results.
Note: This procedure is applicable for cases of acute lymphoblastic leukemia, acute myelogenous leukemia, chronic lymphoproliferative disorders, and malignant lymphomas.
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Leukemia Immunophenotyping, Tissue Panel
Lymphoma Immunophenotyping by Flow Cytometry
Lymphoma Immunophenotyping, Tissue
Tissue Panel, Leukemia Immunophenotyping